We therefore applied Spa-RQ to investigate whether the classification of tumours based on MAPK/mTOR (OL; pERK/p4EBP1) or AKT/mTOR (OL; pAKT/p4EBP1) co-activation signatures translates to human samples. The gene discussed is MTOR; the disease is neoplasm.